The United States on Dec. 16 slapped trade and investment restrictions on dozens of Chinese entities over their role in weaponizing biotechnology and other U.S. innovations to bolster the Chinese military and to further its human rights abuses. Among the 34 Chinese entities targeted was the Academy of Military Medical Sciences—China’s top medical research institute run by the Chinese military—alongside its 11 research institutes, for aiding the Chinese military with biotechnology, including “purported brain-control weaponry,” the department stated without elaborating on the technology. In 2018, the Academy of Military Medical Sciences applied for a patent for technology for collecting and processing brain signals, according to an online patent repository. The Institute of Radiation and Radiation Medicine, one of its subsidiaries that were targeted, published a Chinese paper in 2012 discussing how to establish a data bank on the behavioral effects of “mind control assault weapons.” Trade restrictions were also imposed on …